Organigram Earnings & High Tide Makes Big Move | TTB Powered by Dutchie

Описание: Earnings season continues to roll on as Shadd Dales and Anthony Varrell welcome Beena Goldenberg, CEO of Organigram (NASDAQ: OGI | TSX: OGI), on the latest Trade To Black Podcast.

We unpack Organigram’s latest quarterly results in plain English — revenue momentum, gross margin mix, adjusted EBITDA trajectory, cash position, CapEx discipline, and how pricing, category mix, and retail execution shaped the headline numbers. We compare performance versus Canadian peers, discuss wholesale dynamics and export channels, and flag what the next two quarters could look like if volumes, pricing, and costs hold near current levels.

In Segment Two, Raj Grover, CEO of High Tide (NASDAQ: HITI | TSXV: HITI), joins to break down High Tide’s push into the German medical cannabis market through the acquisition of a majority stake in REMEXIAN Pharma GmbH. We cover why Germany matters now, how this deal complements High Tide’s retail ecosystem and digital platforms, expected timelines and milestones, capital needs, and what success looks like across patient access, product assortment, and margin structure.

We also talk regulatory context, competitive positioning, and how this move could shape High Tide’s international strategy.

Drop your questions in chat for Beena Goldenberg and Raj Grover — we’ll work the best ones into the show. And if you find value in our coverage of Organigram (OGI) and High Tide (HITI), please like, share, and comment to help other investors discover Trade To Black.
0:00:00 Intro
0:01:15 Discussion on Cannabis Rescheduling

Beena Goldenberg Interview
0:07:48 OrganiGram's Q3 Results and Market Position
0:10:29 International Market Opportunities
0:18:19 Cannabis Beverages and Market Trends
0:25:41 Beena's Retirement and Future Plans
0:28:11 Closing Remarks and Future Prospects

Raj Grover Interview
0:30:10 High Tide's Acquisition of Remexian Pharma
0:32:18 High Tide’s Strategy vs. Canadian LPs
0:35:07 Supply Chain and Optionality
0:36:29 Expansion Plans in Germany and EU
0:37:54 Canadian Experience as an Advantage in Germany
0:39:31 German Market Structure and Learning from Canada
0:41:01 Regulatory Concerns in Germany
0:45:13 Retail Expansion and Canna Cabana Stores
0:47:36 Competition in the German Market
0:48:38 Illicit Market and Growth Opportunity
0:50:43 Stock Performance and Market Reaction


0:56:03 German Cannabis Market Expansion
0:57:28 Canadian Cannabis Stocks & Market Trends
0:58:07 Medical Cannabis Safety Incident (Fungal Infection Case)
1:01:04 Need for Research and Rescheduling
1:03:07 Cannabis Policy, Prohibitionists, and Public Perception
1:07:45 Market Inflows, ETFs, and Sector Momentum
1:10:47 Structural Issues in Cannabis Markets
1:12:09 Upcoming Events and Industry Outlook

#CannabisStocks #Organigram #OGI #HighTide #HITI #CannabisInvesting #CannabisNews #GermanCannabis #TradeToBlack #CannabisIndustry #Stocks #marijuanastocks

Want to see our last week's recap?
   • Weekly Recap: Trump Order, SAFER Banking &...  

Want to see more Cannabis Reform videos?
   • Matt Gaetz Urges Trump: Reschedule Cannabi...  
   • Why Rescheduling Could Transform Cannabis ...  
   • Trump Signals Cannabis Rescheduling Decisi...  
   • Ben Shapiro’s Cannabis Shift Explained | T...  

Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com...

Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook:   / thedalesreport  
Twitter:   / thedalesreport  
Instagram:   / dalesreport  
LinkedIn:   / the-dales-report  
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...
Spotify: https://tinyurl.com/TDRTradeToBlackon...
Website: https://thedalesreport.com/

For copyright matters, please get in touch with us at:
[email protected]

All views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have.
https://thedalesreport.com/website-te...